Detection of recurrence by 18F-FDG PET in patients with endometrial cancer showing no evidence of disease

Journal of Korean Medical Science

Volumn 25, Issue 7, 2010, Pages 1029-1033

  Ryu, Sang Young ^a   Kim, Kidong ^a   Kim, Younha ^a   Park, Sang Il ^a   Kim, Beob Jong ^a   Kim, Moon Hong ^a   Choi, Seok Cheol ^a   Lee, Eui Don ^a   Lee, Kyung Hee ^a   Kim, Byung Il ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

Endometrial neoplasms; Positron emission tomography; Recurrence

Indexed keywords

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ENDOMETRIUM TUMOR; FEMALE; HUMAN; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; RETROSPECTIVE STUDY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; TUMOR RECURRENCE;

ADULT; AGED; ENDOMETRIAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 77956552347     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2010.25.7.1029     Document Type: Article

References (18)

1. Irvin WP, Rice LW, Berkowitz RS. Advances in the management of endometrial adenocarcinoma. A review. J Reprod Med 2002; 47: 173-89.
2. John RL. Uterine Cancer, In: Jonathan SB, editor, Berek & Novak's Gynecology. Philadelphia: Lippincott Williams & Wilkins 2007; 1377.
3. Sears JD, Greven KM, Hoen HM, Randall ME. Prognostic factors and treatment outcome for patients with locally recurrent endometrial cancer. Cancer 1994; 74: 1303-8.
4. Israel O, Kuten A. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care. J Nucl Med 2007; 48 (Suppl 1): 28S-35S.
5. Fung-Kee-Fung M, Dodge J, Elit L, Lukka H, Chambers A, Oliver T. Follow-up after primary therapy for endometrial cancer: a systematic review. Gynecol Oncol 2006; 101: 520-9.
6. Bury T, Corhay JL, Duysinx B, Daenen F, Ghaye B, Barthelemy N, Rigo P, Bartsch P. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999; 14: 1376-80.
7. Belhocine T, De Barsy C, Hustinx R, Willems-Foidart J. Usefulness of (18) F-FDG PET in the post-therapy surveillance of endometrial carcinoma. Eur J Nucl Med Mol Imaging 2002; 29: 1132-9.
8. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994; 191: 371-7.
9. Anzai Y, Carroll WR, Quint DJ, Bradford CR, Minoshima S, Wolf GT, Wahl RL. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses. Radiology 1996; 200: 135-41.
10. Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL. Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 1999; 40: 1125-31.
11. Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer. J Nucl Med 2003; 44: 347-52.
12. Zimny M, Siggelkow W, Schroder W, Nowak B, Biemann S, Rath W, Buell U. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer. Gynecol Oncol 2001; 83: 310-5.
13. Saga T, Higashi T, Ishimori T, Mamede M, Nakamoto Y, Mukai T, Fujita T, Togashi K, Yura S, Higuchi T, Kita M, Fujii S, Konishi J. Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer. Ann Nucl Med 2003; 17: 197-203.
14. Sironi S, Picchio M, Landoni C, Galimberti S, Signorelli M, Bettinardi V, Perego P, Mangioni C, Messa C, Fazio F. Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence. Eur J Nucl Med Mol Imaging 2007; 34: 472-9.
15. Hong SJ, Lee SM, Park CS, Kim HA, Kim BJ, Kim MH, Choi SC, Ryu SY, Lee KH. Detection of recurrence with FDG-PET scan in patients with endometrial cancer. Korean J Obstet Gynecol 2004; 47: 295-9.
16. Aalders JG, Abeler V, Kolstad P. Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 1984; 17: 85-103.
17. Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000; 70: 209-62.
18. Chao A, Chang TC, Ng KK, Hsueh S, Huang HJ, Chou HH, Tsai CS, Yen TC, Wu TI, Lai CH. 18F-FDG PET in the management of endometrial cancer. Eur J Nucl Med Mol Imaging 2006; 33: 36-44.